Against the backdrop of trends in the US market, RORZE and Yoshinoya Holdings raised their earnings and dividend forecasts for the fiscal year ending February 2027 in the Tokyo market. Onward Holdings announced a 100th-anniversary commemorative dividend, while Ono Pharmaceutical disclosed a license agreement with US biotech company Biohaven.
Although the major indexes in yesterday’s US stock market moved little overall, several companies are expected to revise their earnings forecasts or announce dividends in the Tokyo market today, drawing investor attention.
RORZE raised its earnings and dividend forecasts for the fiscal year ending February 2027, while Yoshinoya Holdings likewise raised its earnings and dividend forecasts. Onward Holdings announced a 100th-anniversary commemorative dividend. Ono Pharmaceutical signed a license agreement with US biotech company Biohaven. These companies are expected to be the focus of investor buying interest.
In the TSE Standard Market, Ozu Corporation’s first-quarter profit is expected to have reached 2.2 times the year-earlier level, while KG Information is expected to have continued expanding, with operating profit for the first nine months up 62.0%. Companies that have also raised their earnings forecasts are expected to be contrasted with underperforming stocks in some cases.
Meanwhile, WNI Weather’s first-quarter profit fell 2.2%, while Kewpie’s profit growth rate in the first phase narrowed. Sugi Holdings and Ministop are expected to revise their forecasts downward, and the possibility of downward revisions has also been flagged for Terumo, アズ企画設計 and Silicon Studio, among others.